文献库搜索 | GeneLibs

Hörner(M),Tretschock(LM),John(N),Ziegler(P... Breast Cancer Res Treat 2026-04-02

Mutations in PIK3CA are one of several actionable mutations for patients with hormone receptor positive, human epidermal...

Niu(S),Molberg(K),Carrick(K),Colon(GR),Gwi... Int J Gynecol Pathol 2026-07-01

...PIK3CA (18%), PIK3R1 (18%), PTEN (18%), AKT1 (18%), TP53 (18%), and several others (≤18%). In contrast, SMBTs lacked CTN...

Chen(D),Chen(T),Yang(Y),Wang(A) Mol Clin Oncol 2026-05-00

...PIK3CA (PDB ID: 9B4T) and PSO. In vitro experiments demonstrated a potent antiproliferative effect of PSO on multiple RC...

Dickerson(JC),McClure(MB),Shaw(M),Reitsma(... medRxiv 2026-03-25

...PIK3CA mutation status, and 90% for ESR1 mutation status. For anti-cancer drug extraction, the best-performing LLM appro...

Qu(HQ),Li(D),Hakonarson(H) Front Neurol None

...PIK3CA-mediated pathology, and MEK inhibition for RAS/MAPK-driven lesions. We summarize translational and clinical evide...

Shibamori(K),Hashimoto(K),Okabe(K),Maehana... Front Urol None

...PIK3CA (E545K) gene mutation in surgical smoke collected through a water trap system during RARC. However, we were unabl...

Abd El-Salam(M),Chen(W),Tang(Y),Rao(T),Kan... Transl Oncol 2026-05-00

...PIK3CA-mutant non-small cell lung cancer (NSCLC), their clinical impact is limited due to compensatory activation of ins...

Huang(Y),Shao(J),Yin(X),Jiang(Y),Luo(J),Hu... Curr Cancer Drug Targets 2026-04-03

...PIK3CA mutations could indicate a negative association. Additionally, TP53 mutations were linked to high HRD scores in B...

Samghabadi(P),Ding(C),Khorsandi(N),Lu(KL),... Mod Pathol 2026-06-00

...PIK3CA, KMT2C, and FAT1.

Manzano(JAH),Abellanosa(EAM),Aguilar(JPP),... ACS Omega 2026-03-31

...PIK3CA, and MAPK14 p38α emerging as putative key regulators. Molecular docking revealed strong binding energies (-10.1, ...